Dry Powder Inhalation of Particles Containing Anti-tuberculosis Drugs | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Dry Powder Inhalation of Particles Containing Anti-tuberculosis Drugs

Implementing Organization

Central Research Institute (CRI)

Central Drug Research Institute (CDRI)

About

Treatment of pulmonary TB with orally-administered drugs is sub-optimal-exposing non-target tissues to toxic drugs and requiring large doses to build up effective concentrations in lungs . Prolonged dosing is required to build up and maintain effective concentrations in lungs . Patients remain infectious for considerable periods after initiating drug treatment.

Patent Details

ZA200603256

Related Research

Quick Information

Area of Research

Medical Sciences

Focus Area

Treatment of Pulmonary TB

Status

completed

Patent No.

ZA200603256

Output in Numbers

Research Paper

00

Technologies (If Any)

00

PhD Produced

N/A

Startup (If Any)

00

Patents

Filed :01

Grant :00